← Eichor
Study identifier: NCT03334006 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis

Condition: Peritonitis · Sepsis · Septic Shock  ·  Sponsor: RWTH Aachen University

PhasePhase 2
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this prospective, randomized, controlled trial is to provide evidence for adjuvant IgGAM treatment with regard to 1. Improvement of patient outcomes for peritonitis. Improvement in outcome will be determined by scores such as MOF, SOFA and survival. 2. Identification of biomarkers (including immunoglobulin levels, HLA-DR, NF-kB1 and other immunological biomarkers) to identify patient subpopulations that benefit most from IgGAM treatment. These patients will form the basis for a further randomized, controlled, double-blind Phase III trial (RCT) to demonstrate the benefit of this treatment. 3. In addition, these biomarkers could help to guide a targeted, i.e. "personalized", adjuvant therapy with Pentaglobin® (IgGAM) in the indication of peritonitis.

This description comes directly from the study's public registry record.

Talk to the study team

Center for Translational & Clinical Research (CTC-A)  ·  PEPPER@ukaachen.de

Always discuss trial participation with your own doctor first.

Locations (20)

Medizinische Universität Wien, Klinische Abteilung für Allgemeine Anästhesie und IntensivmedizinVienna, AustriaRecruiting
Universitätsklinikum Tübingen, Universitätsklinik für Anästhesiologie und IntensivmedizinTübingen, Baden-Wurttemberg, GermanyTerminated
Universitätsklinikum Regensburg, Klinik für AnästhesiologieRegensburg, Bavaria, GermanyRecruiting
Universitätsklinikum Essen, Klinik für Anästhesiologie und IntensivmedizinEssen, North Rhine-Westphalia, GermanyRecruiting
Charité - Universitätsmedizin Berlin, Klinik für Anästhesiologie mit Schwerpunkt operative IntensivmedizinBerlin, State of Berlin, GermanyRecruiting
Uniklinik RWTH Aachen, Klinik für Operative Intensivmedizin und Intermediate CareAachen, GermanyRecruiting
Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Klinik für Anästhesiologie, Intensivmedizin und SchmerztherapieBochum, GermanyRecruiting
Klinikum Westfalen, Knappschaftskrankenhaus Dortmund, Klinik für Anästhesiologie, operative Intensivmedizin und SchmerztherapieDortmund, GermanyTerminated
Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Anästhesiologie und IntensivtherapieDresden, GermanyWithdrawn
Universitätsklinikum Düsseldorf, Klinik für AnästhesiologieDüsseldorf, GermanyWithdrawn
Universitätklinikum Frankfurt, Klinik für Anästhesiologie, Intensivmedizin und SchmerztherapieFrankfurt, GermanyRecruiting
Universitätsklinikum Freiburg, Klinik für Allgemein- und ViszeralchirurgieFreiburg im Breisgau, GermanyRecruiting

+ 8 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03334006